Atossa Therapeutics, Inc.
ATOS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001488039
No open-market purchases or sales by Atossa Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $2.60M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Atossa Therapeutics, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 67 | 2 | 33 | −32 |
| SharesConverted for a 1-for-15 split | 1.47M | 411.1K | 1.24M | +185.6K (+17.6%) |
| Value | $13.0M | $3.64M | $6.52M | −$2.81M (−30.1%) |
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Atossa Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 349,096 | $1.84M | 0.00% |
| Vanguard Fiduciary Trust Co | 52,235 | $274.8K | 0.00% |
| Vanguard Global Advisers, LLC | 3,089 | $16.2K | 0.00% |
| Avion Wealth | 318 | $1.00K | 0.00% |
| North Star Investment Management Corp. | 80 | $421 | 0.00% |
| Napier Financial, LLC | 6 | $32 | 0.00% |
| Bogart Wealth, LLC | 5 | $26 | 0.00% |
Sold out (39)
Institutions that held Atossa Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
Not filed for Q1 2026 yet (2)
Institutions that held Atossa Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 6,147,838 | $3.63M |
| Greenberg Financial Group | 18,216 | $10.7K |